French Consortium Launches Production for Saliva-Based COVID Screening Test

PARIS (Reuters) -
Specimens from coronavirus disease (COVID-19) tests are logged to be processed for a positive or negative result at the UW Medicine Virology lab in Seattle, Washington, March 18. (Reuters/Brian Snyder/File Photo)

A French consortium announced on Monday the launch of the production phase for a saliva-based screening test to detect the COVID-19 coronavirus.

The consortium said the test would be performed by a health-care professional and involves collecting less than 1 milliliter of saliva from a patient. The sample is then deposited in two tubes heated to 65 degrees Celsius, and a subsequent reading screens the tested patients for the presence of the virus.

The consortium – comprised of French companies Vogo, SKILLCELL and the CNRS SYS2DIAG laboratory – hoped its “EasyCov” product would enter the French market from mid-June onwards.